Phase III Trial of Stage I Ovarian Cancer After Surgery
Phase 3
Recruiting
- Conditions
- Epithelial Ovarian Cancer
- Interventions
- Drug: adjuvant chemotherapy
- First Posted Date
- 2019-08-21
- Last Posted Date
- 2019-08-30
- Lead Sponsor
- Japanese Gynecologic Oncology Group
- Target Recruit Count
- 360
- Registration Number
- NCT04063527
- Locations
- 🇯🇵
Tokyo Metropolitan Tama Medical Center, Fuchu-shi, Tokyo, Japan
🇯🇵Sasaki Faundation Kyoundo Hospital, Chiyoda, Tokyo, Japan
🇯🇵Tokyo Medical And Dental University University Hospital of Medicine, Bunkyō-Ku, Tokyo, Japan
Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma
Phase 3
Completed
- Conditions
- Primary Peritoneal CancerEpithelial Ovarian CancerFallopian Tube Cancer
- Interventions
- Drug: Paclitaxel+Carboplatin
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- Japanese Gynecologic Oncology Group
- Target Recruit Count
- 637
- Registration Number
- NCT00226915
- Locations
- 🇯🇵
National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
© Copyright 2025. All Rights Reserved by MedPath